Related Experiment Video
Updated: Jun 10, 2026
09:32
A Next-generation Tissue Microarray (ngTMA) Protocol for Biomarker Studies
Published on: September 23, 2014
Immunohistochemical analysis of tissue microarrays
Ronald Simon1, Martina Mirlacher, Guido Sauter
1Institute of Pathology, University Medical Center Hamburg Eppendorf, Hamburg, Germany.
Methods in Molecular Biology (Clifton, N.J.)
|August 7, 2010
Summary
Immunohistochemistry (IHC) combined with tissue microarray (TMA) enables standardized protein analysis in many samples. Optimizing IHC protocols and using controls are crucial for accurate results in TMA studies.
Area of Science:
- Biomedical Sciences
- Pathology
- Molecular Biology
Background:
- Immunohistochemistry (IHC) is the standard for in-situ protein analysis.
- Tissue microarray (TMA) technology allows high-throughput analysis of numerous tissue samples.
- Standardized protocols are essential for reliable IHC results, especially with TMAs.
Purpose of the Study:
- To highlight the importance of optimizing IHC protocols for TMA studies.
- To emphasize the necessity of control experiments for validating antibody specificity.
Main Methods:
- Utilizing IHC in conjunction with TMA technology.
- Applying standard immunostaining protocols, including antigen retrieval for formalin-fixed tissues.
- Implementing preabsorption and isotype-specific controls during protocol development.
Main Results:
- IHC and TMA enable standardized, simultaneous analysis of hundreds of tissue samples.
- Established IHC protocols are transferable to TMA formats.
- Protocol optimization significantly impacts staining outcomes.
- Control experiments confirm target protein-specific antibody binding.
Conclusions:
- Optimized IHC protocols are critical for the success of TMA-based protein expression studies.
- Including specific controls is essential for validating antibody performance and ensuring data accuracy in TMA research.
